COMMUNIQUÉS West-GlobeNewswire

Starton Therapeutics Announces Successful Feasibility Demonstration of STAR-LLD Using BD Evolve™ On-Body Injector

18/09/2024 - 16:46

Successful feasibility study underscores compatibility of STAR-LLD using On-body Injector (OBI) technology and Starton’s proprietary low-dose formulation of lenalidomide (LLD) Based on the positive feasibility study [...]

Tilray Medical lance la marque de cannabis Redecan en Australie

18/09/2024 - 16:11

Le cannabis Redecan, certifié BPF-UE, est désormais disponible sur prescription médicale en Australie NEW YORK, 18 sept. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. ("Tilray Brands") ( [...]

Corza Medical figure dans la liste MedTech Big 100 de 2024

18/09/2024 - 16:06

WESTWOOD, Massachusetts, 18 sept. 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” ou l'“Entreprise”), une entreprise de technologie médicale de premier rang à l'échelle mondiale, dédiée à proposer des services [...]

Kaida BioPharma Launches Social Media Channels

18/09/2024 - 16:00

Company dedicated to providing a new hope for patients with treatment-resistant gynecological cancers Lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1 study, targeted for 2025 [...]

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

18/09/2024 - 16:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the [...]

Dallas Neurosurgical & Spine Doctors Provide Tips to Take the “Pain” out of National Pain Awareness Month

18/09/2024 - 15:46

PLANO, Texas, Sept. 18, 2024 (GLOBE NEWSWIRE) -- September is National Pain Awareness Month – an ideal time to explore causes and treatment methods for back pain, which is widely reported as one of the world’s most [...]

Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones

18/09/2024 - 15:30

Initiated Phase IIb study of nature-derived psilocybin as a potential treatment for Adjustment Disorder in Palliative Care Expanded pipeline into Alcohol Use Disorder (AUD) and Substance Use Disorders (SUDs) through [...]

Business update - opdatering på identitetsændring:

18/09/2024 - 15:26

Selskabet annoncerede i selskabsmeddelelse 13/2024, at man havde indledt en proces med at gennemføre et identitetsskifte med Nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab. Nasdaq har dags dato [...]

SupplyCopia Unveils Groundbreaking AI Solutions at AHRMM24

18/09/2024 - 15:15

Transforming Healthcare Supply Chains and Driving CQO Through AI Innovation BRIDGEWATER, N.J., Sept. 18, 2024 (GLOBE NEWSWIRE) -- SupplyCopia is thrilled to announce its participation at the AHRMM24 Conference, where it [...]

Marius Pharmaceuticals Partners with UK-Based Numan to Combat Testosterone Deficiency with KYZATREX® (Testosterone Undecanoate) CIII Capsules

18/09/2024 - 15:00

RALEIGH, N.C., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce a new partnership with Numan , a leading UK-based, VC-backed digital health platform, to introduce KYZATREX ® (testosterone [...]

Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan

18/09/2024 - 15:00

PALO ALTO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

GRI Bio Participates in Virtual Investor KOL Connect Segment

18/09/2024 - 15:00

Albert Agro, PhD, CMO of GRI Bio recently participated in a Virtual Investor KOL Connect segment with prominent key opinion leader in Idiopathic Pulmonary Fibrosis (IPF) – Dr. Helen Parfrey, Respiratory Consultant at [...]

NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection

18/09/2024 - 15:00

LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]

Corza Medical Named to the 2024 MedTech Big 100 List

18/09/2024 - 14:55

WESTWOOD, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, is [...]

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

18/09/2024 - 14:54

- Transaction Will Maximize the Access and Uptake of COSELA ® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent - - G1 Stockholders to Receive U.S. $7.15 Per Share in Cash - HOLBAEK, Denmark [...]

Notice of Annual General Meeting 2024

18/09/2024 - 14:45

ANNOUNCEMENT NO. 275 18 September 2024 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 10 October 2024 at 5.30 p.m. The general meeting will be held [...]

Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104

18/09/2024 - 14:45

Data continues to differentiate ‘1104 as a potential allergic disease treatment that acts upstream in the immune cascade ‘1104 reduces key indices of skin inflammation and inflammatory mediators in a chronic allergen- [...]

Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024

18/09/2024 - 14:30

Presentations Will Highlight Oral Prolonged-Release Ketamine (KET01) And its Minimal Impact on Sleep, Alongside Excellent Day-One Tolerability in Patients MUNICH, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ketabon GmbH (“ [...]

Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors

18/09/2024 - 14:30

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet [...]